Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.50832?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121324
Prevalence of Post–COVID-19 Condition and Activity-Limiting Post–COVID-19 Condition Among Adults
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, FRIDAY, DECEMBER 13, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.51151?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121324
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: In 2023, among 29,522 respondents to the National Health Interview Survey, a nationally representative household survey, 8.4% of adults in the U.S. reported they ever had post–COVID-19 condition (PCC; also known as long COVID), 3.6% currently had PCC, and 2.3% currently had activity-limiting PCC. Significant differences across all 3 outcomes were observed by sex, sexual orientation, age, race and Hispanic origin, family income, and urbanization.
Corresponding Author: To contact the corresponding author, Anjel Vahratian, PhD, MPH, email avahratian@cdc.gov.
(doi:10.1001/jamanetworkopen.2024.51151)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Changes in Adult Obesity Trends in the US
JAMA Health Forum
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, DECEMBER 13, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.3685?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121324
About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
About The Study: The findings of this study suggest that body mass index and obesity prevalence in the U.S. decreased in 2023 for the first time in more than a decade. The most notable decrease was in the South, which had the highest observed per capita glucagon-like peptide 1 receptor agonist (GLP-1RA) dispensing rate. However, dispensing does not necessarily mean uptake, and the South also experienced disproportionately high COVID-19 mortality among individuals with obesity.
Corresponding Author: To contact the corresponding author, Benjamin Rader, PhD, MPH, email benjamin.rader@childrens.harvard.edu.
(doi:10.1001/jamahealthforum.2024.3685)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer
JAMA
EMBARGOED FOR RELEASE: 11:15 A.M. ET, FRIDAY, DECEMBER 13, 2024
Media advisory: The full study is linked to this news release. This study is being presented at the San Antonio Breast Cancer Symposium.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.23560?guestAccessKey=1f9e55e6-3a16-43df-9459-4a0040abc9c0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121324
About The Study: Among patients with early or locally advanced triple-negative breast cancer, the addition of camrelizumab, an anti–PD-1 antibody, to neoadjuvant chemotherapy significantly improved pathological complete response.
Corresponding Authors: To contact the corresponding authors, email Zhi-Ming Shao, MD (zhiminshao@fudan.edu.cn) and Lei Fan, MD (teddyfl@163.com).
(doi:10.1001/jama.2024.23560)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ
JAMA Oncology
EMBARGOED FOR RELEASE: 8:15 A.M. (ET), THURSDAY, DECEMBER 12, 2024
Media advisory: The full study is linked to this news release. This study is being presented at the San Antonio Breast Cancer Symposium.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.6556?guestAccessKey=0eeee72d-bf97-4638-861c-42bfa16a41a5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121224
About The Study: In this prespecified secondary analysis of the Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) prospective randomized trial, the overall lived experience of women randomized to undergo active monitoring for low-risk ductal carcinoma in situ was similar to that of women randomized to guideline-concordant care during the 2 years following diagnosis.
Corresponding Author: To contact the corresponding author, Ann H. Partridge, MD, MPH, email ann_partridge@dfci.harvard.edu.
(doi:10.1001/jamaoncol.2024.6556)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ
JAMA
EMBARGOED FOR RELEASE: 8:15 A.M. ET, THURSDAY, DECEMBER 12, 2024
Media advisory: The full study and editorial are linked to this news release. This study is being presented at the San Antonio Breast Cancer Symposium.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.26698?guestAccessKey=e1ebba48-d10d-4114-8084-88cdc40c929c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121224
About The Study: Women with low-risk ductal carcinoma in situ randomized to active monitoring did not have a higher rate of invasive cancer in the same breast at 2 years compared with those randomized to guideline-concordant care.
Corresponding Author: To contact the corresponding author, E. Shelley Hwang, MD, MPH, email shelley.hwang@duke.edu.
(doi:10.1001/jama.2024.26698)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Neighborhood Disadvantage in a Nationally Representative Sample of Community-Living Older US Adults
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.50332?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121224
Nonsupine Sleep Position Among US Infants
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.50277?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121224
Anabolic Steroid Initiation Among Boys and Young Men After Use of Muscle-Building Supplements
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.50566?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121224
Pfizer-BioNTech Vaccine for COVID-19 Among Children Ages 5-17
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, THURSDAY, DECEMBER 12, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49944?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121224
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: The results of this study suggest that the BNT162b2 XBB vaccine (Pfizer-BioNTech) provided protection against COVID-19–associated hospitalization and emergency department or urgent care visits among children 5 to 17 years of age during the 2023-2024 season with estimated vaccine effectiveness point estimates ranging from 63% to 73%.
Corresponding Author: To contact the corresponding author, Sara Y. Tartof, PhD, MPH, email Sara.Y.Tartof@kp.org.
(doi:10.1001/jamanetworkopen.2024.49944)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Trends in School Mental Health and Substance Use Education
JAMA
EMBARGOED FOR RELEASE: 11 A.M. ET, THURSDAY, DECEMBER 12, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.24579?guestAccessKey=3608d845-bedd-446c-b52d-8b93d0b86339&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121224
About The Study: From 2008-2020, teachers reported an increase in emotional/mental health and suicide prevention in schools, along with related teacher training. However, they reported a decrease in substance use prevention, particularly among middle schools, and no change in teacher training. Substance use during early adolescence is associated with risk for long-term addiction, and middle schools may be underused for prevention.
Corresponding Author: To contact the corresponding author, Chloe Gao, BHSc, email chloe.gao@childrens.harvard.edu.
(doi:10.1001/jama.2024.24579)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Buprenorphine Injection Among Rural Persons Who Inject Drugs
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.50108?guestAccessKey=f4e1b1b7-89fc-4d66-aef2-a28a57e0f0cd&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121124
Public Attitudes Toward Notification of Use of AI in Health Care
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.50102?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121124
Global Healthspan-Lifespan Gaps Among 183 WHO Member States
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, WEDNESDAY, DECEMBER 11, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.50241?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121124
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: This study identifies growing healthspan (years lived in good health)-lifespan gaps around the globe, threatening healthy longevity across worldwide populations. Women globally exhibited a larger healthspan-lifespan gap than men.
Corresponding Author: To contact the corresponding author, Andre Terzic, MD, PhD, email terzic.andre@mayo.edu.
(doi:10.1001/jamanetworkopen.2024.50241)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Electronic Sepsis Screening Among Patients Admitted to Hospital Wards
JAMA
EMBARGOED FOR RELEASE: 11:30 P.M. ET, TUESDAY, DECEMBER 10, 2024
Media advisory: The full study and editorial are linked to this news release. This study is being presented at the Critical Care Reviews Down Under meeting.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.25982?guestAccessKey=24f9df52-423a-478f-9da1-077914ec92f0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121024
About The Study: Among hospitalized ward patients, electronic sepsis screening compared with no screening resulted in significantly lower in-hospital 90-day mortality.
Corresponding Author: To contact the corresponding author, Yaseen M. Arabi, MD, email arabi@ngha.med.sa.
(doi:10.1001/jama.2024.25982)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure
JAMA
EMBARGOED FOR RELEASE: 7 P.M. ET, TUESDAY, DECEMBER 10, 2024
Media advisory: The full study and editorials are linked to this news release. This study is being presented at the Critical Care Reviews Down Under meeting.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.26244?guestAccessKey=44a6ef73-fb24-4f13-ab29-bff421845107&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121024
About The Study: Compared with noninvasive ventilation, high-flow nasal oxygen met prespecified criteria for noninferiority for the primary outcome of endotracheal intubation or death within 7 days in 4 of the 5 patient groups with acute respiratory failure. However, the small sample sizes in some patient groups and the sensitivity of the findings to the choice of analysis model suggests the need for further study in patients with chronic obstructive pulmonary disease, immunocompromised patients, and patients with acute cardiogenic pulmonary edema.
Corresponding Author: To contact the corresponding author, Alexandre Biasi Cavalcanti, MD, PhD, email abiasi@hcor.com.br.
(doi:10.1001/jama.2024.26244)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis
JAMA
EMBARGOED FOR RELEASE: 5 P.M. ET, MONDAY, DECEMBER 9, 2024
Media advisory: The full study is linked to this news release. This study is being presented at the Critical Care Reviews Down Under meeting.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.26458?guestAccessKey=bececbf0-6542-489f-88dd-1e444426bd6a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120924
About The Study: In hospitalized adults, daily procalcitonin -guided protocol reduced antibiotic duration safely compared with standard care, but daily C-reactive protein -guided protocol does not. All-cause mortality for C-reactive protein was inconclusive.
Corresponding Author: To contact the corresponding author, Paul Dark, MD, PhD, email adaptsepsistrial@warwick.ac.uk.
(doi:10.1001/jama.2024.26458)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Treatment Expectancies and Psilocybin vs Escitalopram for Depression
JAMA Psychiatry
EMBARGOED FOR RELEASE: 7 P.M. (ET), MONDAY, DECEMBER 9, 2024
Media advisory: The full study is linked to this news release. This study is being presented at the American College of Neuropsychopharmacology Annual Meeting.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2024.4387?guestAccessKey=30ed1c66-ba42-48e8-91ba-d6d50ca38e2b&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120924
About The Study: This randomized controlled trial secondary analysis examines the association between treatment expectancies and the relative efficacy of psilocybin compared with escitalopram for major depressive disorder.
Corresponding Author: To contact the corresponding author, Ethan Dutcher, MD, PhD, email ethan.dutcher@ucsf.edu.
(10.1001/jamapsychiatry.2024.4387)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Early Restrictive vs Liberal Oxygen for Trauma Patients
JAMA
EMBARGOED FOR RELEASE: 5 P.M. ET, TUESDAY, DECEMBER 10, 2024
Media advisory: The full study is linked to this news release. This study is being presented at the Critical Care Reviews Down Under meeting.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.25786?guestAccessKey=abe95d01-d7ca-4037-b048-412030f3ede7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121024
About The Study: In adult trauma patients, an early restrictive oxygen strategy compared with a liberal oxygen strategy initiated in the prehospital setting or on trauma center admission for 8 hours did not significantly reduce death and/or major respiratory complications within 30 days.
Corresponding Author: To contact the corresponding author, Jacob Steinmetz, MD, PhD, email jacob.steinmetz@regionh.dk.
(doi:10.1001/jama.2024.25786)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Glycemic Control With Layperson-Delivered Telephone Calls vs Usual Care for Patients With Diabetes
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.48809?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121024
Agent-Based Model of Combined Community- and Jail-Based Take-Home Naloxone Distribution
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.48732?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121024
Patient Gowns and Dehumanization During Hospital Admission
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49936?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121024
Race, Ethnicity, and Sleep in US Children
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, TUESDAY, DECEMBER 10, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49861?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121024
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: In this cross-sectional study of children’s sleep disparities, racially and ethnically minoritized children exhibited disparities in mean levels and variability of sleep compared with their white peers. These findings suggest that policies and practices should target multiple sleep dimensions among diverse racial and ethnic groups to promote equitable pediatric sleep health.
Corresponding Author: To contact the corresponding author, Yijie Wang, PhD, email yjwang@msu.edu.
(doi:10.1001/jamanetworkopen.2024.49861)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Allostatic Load, Educational Attainment, and Risk of Cancer Mortality Among US Men
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, TUESDAY, DECEMBER 10, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49855?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121024
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: This study highlights the detrimental association of not attaining a high school degree, combined with high allostatic load as a marker of chronic stress, with cancer mortality. Efforts to promote educational attainment and address the underlying social determinants of health are imperative in reducing cancer disparities in this population.
Corresponding Author: To contact the corresponding author, Justin X. Moore, PhD, MPH, email jx.moore@uky.edu.
(doi:10.1001/jamanetworkopen.2024.49855)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Asthma Prevalence in the Disaggregated Multiracial Population of California
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49588?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120924
Depression Treatment After a Positive Depression Screen Result
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2024.6211?guestAccessKey=31ca7e47-d74f-4ef8-b4de-c1fb415a11ae&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120924
State Parental Consent Law and Treatment Use Among Adolescents With Depression
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2024.5361?guestAccessKey=e365fca1-13a4-45ae-8bf7-5230447a75f1&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120924
Stress-Related Disorders Among Young Individuals With Surgical Removal of Tonsils or Adenoids
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, MONDAY, DECEMBER 9, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49807?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120924
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: The findings of this cohort study suggest that early-life surgical removal of tonsils or adenoids is associated with a higher future risk of stress-related disorders and highlight a need to understand the role of adenotonsillar diseases or associated health conditions in the development of stress-related psychiatric disorders.
Corresponding Author: To contact the corresponding author, Zhe Zhang, MD, PhD, email zhangzhe@gxmu.edu.cn.
(doi:10.1001/jamanetworkopen.2024.49807)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Health and Lifestyle Factors and Dementia Risk Among Former Professional Soccer Players
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, MONDAY, DECEMBER 9, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49742?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120924
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: This cohort study found no evidence that high dementia risk among former professional soccer players was associated with potentially modifiable general health and lifestyle dementia risk factors. These data support continuation of measures directed toward reducing exposure to repetitive head impacts and traumatic brain injury in sport.
Corresponding Author: To contact the corresponding author, William Stewart, MBChB, PhD, email william.stewart@glasgow.ac.uk.
(doi:10.1001/jamanetworkopen.2024.49742)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
RSV Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
JAMA Pediatrics
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, DECEMBER 9, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2024.5572?guestAccessKey=c8c52317-1d0c-4ed7-8c77-83f33f2e1782&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120924
About The Study: This analysis documented the continued high burden of medically attended respiratory syncytial virus (RSV)-associated acute respiratory illness among young children in the U.S. Nirsevimab and maternal RSV vaccine uptake was low, but nirsevimab was effective against RSV-associated hospitalization. There is a potential for substantial public health impact with increased and equitable prevention product coverage in future seasons.
Corresponding Author: To contact the corresponding author, Heidi L. Moline, MD, MPH, email ick6@cdc.gov.
(doi:10.1001/jamapediatrics.2024.5572)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Racial and Ethnic and Rural Variations in the Use of Hybrid Prenatal Care in the US
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49243?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120624
Stakeholder Perspectives on Randomized Clinical Trials for Children With Poor-Prognosis Cancers
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49239?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120624
Drug Overdose Deaths Among Medicaid Beneficiaries
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.4365?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120624
About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
Cholesterol, Triglyceride, and Glucose Levels Across Birth Cohorts in the US
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, FRIDAY, DECEMBER 6, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49481?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120624
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: In this cross-sectional study of 52,000 participants representing 264 million U.S. adults, population-level improvements in total cholesterol and triglyceride levels decelerated and adverse trends in glucose levels accelerated in more recent birth cohorts, which was partially mediated by concurrent increases in body mass index. Public health initiatives that target antecedent health behaviors are needed to improve cardiometabolic health across generations.
Corresponding Author: To contact the corresponding author, Xiaoning Huang, PhD, email jack.huang@northwestern.edu.
(doi:10.1001/jamanetworkopen.2024.49481)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Loneliness and Social Isolation Among US Older Adults
JAMA
EMBARGOED FOR RELEASE: 11 A.M. ET, MONDAY, DECEMBER 9, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.23213?guestAccessKey=6cc10a4c-125a-45c4-aef8-6869c2776dd6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120924
About The Study: This study found that adults ages 50 to 80 commonly reported loneliness and social isolation. While the pandemic disrupted social connections, rates of loneliness and isolation were substantial both before and after the early pandemic. High rates of loneliness and social isolation occurred in several sociodemographic groups, especially those with self-reported fair or poor physical or mental health.
Corresponding Author: To contact the corresponding author, Preeti N. Malani, MD, MSJ, email pmalani@umich.edu.
(doi:10.1001/jama.2024.23213)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Diversion of Undistributed Pharmaceutical Ketamine in the US
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.23014?guestAccessKey=c9c8fde6-6294-449d-9dc1-f540a32a99e7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120524
Discrimination Within the US Ophthalmology Workforce
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2024.5139?guestAccessKey=15def9fb-39f4-454d-a183-302125cd27ed&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120524
Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49026?guestAccessKey=9e01c33a-bdf1-4945-a6a5-29a52828ad12&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120524
Satellite-Based and Street-View Green Space and Adiposity in US Children
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, THURSDAY, DECEMBER 5, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49113?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120524
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: The results of this cohort study of U.S. children suggest that higher levels of satellite-based normalized difference vegetation index greenness and percentages of street-level green space components (flowers, plants, and fields) were associated with lower adiposity. The findings support the exploration of increasing residential green space levels and adding specific green space components as an urban planning and public health intervention strategy to combat the prevalence of childhood obesity in the U.S.
Corresponding Author: To contact the corresponding author, Li Yi, PhD, email li_yi@hsph.harvard.edu.
(doi:10.1001/jamanetworkopen.2024.49113)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Estimated Reduction in Health Care Spending Associated With Weight Loss in Adults
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, THURSDAY, DECEMBER 5, 2024
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49200?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120524
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: In this cross-sectional study, projected annual savings from weight loss among U.S. adults with obesity were substantial for both Medicare and employer-based insurance.
Corresponding Author: To contact the corresponding author, Kenneth E. Thorpe, PhD, email kthorpe@emory.edu.
(doi:10.1001/jamanetworkopen.2024.49200)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020
JAMA Oncology
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 5, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.5381?guestAccessKey=b09bd8fb-cf28-4cda-be14-5d139146d1d5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120524
About The Study: In this model-based study using population-level cancer mortality data, an estimated 5.94 million cancer deaths were averted for breast, cervical, colorectal, lung, and prostate cancers combined from 1975 to 2020. Prevention and screening accounted for 8 of every 10 averted deaths, and the contribution varied by cancer site. Despite progress, efforts to reduce the U.S. cancer burden will require increased dissemination of effective interventions and new technologies and discoveries.
Corresponding Author: To contact the corresponding author, Katrina A. B. Goddard, PhD, email katrina.goddard@nih.gov.
(doi:10.1001/jamaoncol.2024.5381)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Obstetric Care Access at Rural and Urban Hospitals in the US
JAMA
EMBARGOED FOR RELEASE: 11 A.M. ET, WEDNESDAY, DECEMBER 4, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.23010?guestAccessKey=ac30e1b3-5c77-48e0-a293-5e9261a566d1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120424
About The Study: Between 2010 and 2022—a time of tremendous attention to maternal health—there was a net loss of hospital-based obstetric care in both rural and urban hospitals across the U.S. In 2010, more than half of rural hospitals and two-thirds of urban hospitals offered obstetric care. Rural hospitals started with lower percentages of hospitals offering obstetrics compared with urban hospitals and experienced a larger increase in the percentage of hospitals without obstetrics.
Corresponding Author: To contact the corresponding author, Katy B. Kozhimannil, PhD, MPA, email Brad Robideau at brobidea@umn.edu.
(doi:10.1001/jama.2024.23010)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Redesigning the Hospital Environment to Improve Restfulness
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.47790?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120424
Symptom Recovery in Children Ages 5 to 12 With Sport-Related and Non–Sport-Related Concussion
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.48797?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120424
Duration of Ice Hockey Play and CTE
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49106?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120424
Accuracy in Measurement of Infant Formula Powder and Water by Caregivers With and Without a Crying Baby Present
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.47362?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120424
Racial and Ethnic Disparities in Regulatory Air Quality Monitor Locations in the US
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, WEDNESDAY, DECEMBER 4, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49005?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120424
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: The findings of this study suggest regulatory monitor data may not adequately capture air quality exposures for some marginalized race and ethnicity groups, and the consequences of incomplete or uncertain air quality estimates for these communities should be further investigated.
Corresponding Author: To contact the corresponding author, Brenna C. Kelly, MS, email brenna.kelly@utah.edu.
(doi:10.1001/jamanetworkopen.2024.49005)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Trends in Outpatient Psychotherapy Among Adults in the US
JAMA Psychiatry
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, DECEMBER 4, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2024.3903?guestAccessKey=5ab63cdd-d387-44d3-b9cf-8072c5a3efd9&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120424
About The Study: This study found that psychotherapy use increased significantly faster among several socioeconomically advantaged groups and that inequalities were evident in teletherapy access. These trends and patterns highlight a need for clinical interventions and health care policies to broaden access to psychotherapy including teletherapy.
Corresponding Author: To contact the corresponding author, Mark Olfson, MD, MPH, email mo49@cumc.columbia.edu.
(10.1001/jamapsychiatry.2024.3903)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.48215?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120324
Acceptability of Guidelines to Stop Colon Cancer Screening by Estimated Life Expectancy
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.47802?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120324
Use of AI in Peer Review Among Top 100 Medical Journals
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.48609?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120324
Developing and Evaluating Large Language Model–Generated Emergency Medicine Handoff Notes
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, TUESDAY, DECEMBER 3, 2024
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.48723?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120324
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: In this cohort study of 1,600 emergency medicine patient medical records, large language model (LLM)-generated emergency medicine-to-inpatient handoff notes were determined superior compared with physician-written summaries via conventional automated evaluation methods, but marginally inferior in usefulness and safety via a novel evaluation framework. This study suggests the importance of a physician-in-loop implementation design for this model and demonstrates an effective strategy to measure pre-implementation patient safety of LLM models.
Corresponding Author: To contact the corresponding author, Vince Hartman, MS, email vince@abstractivehealth.com.
(doi:10.1001/jamanetworkopen.2024.48723)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Disease Severity Staging System for NOTCH3-Associated Small Vessel Disease, Including CADASIL
JAMA Neurology
EMBARGOED FOR RELEASE: 3 A.M. (ET), FRIDAY, NOVEMBER 29, 2024
Media advisory: The full study is linked to this news release. The study is being presented at the CADASIL meeting 2024.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2024.4487?guestAccessKey=1159cb3b-9fd9-47ed-89c3-ffc0051dcb01&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112924
About The Study: The findings of this study suggest the NOTCH3-associated small vessel disease (NOTCH3-SVD) staging system will help to better harmonize NOTCH3-SVD and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) cohort studies and registries; may improve individualized disease counseling, monitoring, and clinical management; and may facilitate patient stratification in clinical trials.
Corresponding Authors: To contact the corresponding authors, email Gido Gravesteijn, MD, PhD (g.gravesteijn@lumc.nl) and Saskia A. J. Lesnik Oberstein, MD, PhD (lesnik@lumc.nl).
(doi:10.1001/jamaneurol.2024.4487)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Drug Prices Negotiated by Medicare vs US Net Prices and Prices in Other Countries
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22582?guestAccessKey=a6627c2b-b43c-43eb-ac14-2ea566fe7716&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120224
Advance Care Planning, End-of-Life Preferences, and Burdensome Care
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2024.6215?guestAccessKey=f0be22b8-b469-49a0-a96a-7250ae7b09f5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120224
Smartphone App–Based Contingency Management and Opioid Use Disorder Treatment Outcomes
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.48405?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120224
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel
JAMA
EMBARGOED FOR RELEASE: 11 A.M. ET, SUNDAY, DECEMBER 1, 2024
Media advisory: The full article and editorial are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.24543?guestAccessKey=d894a41c-50a3-4496-b825-56fee9b1e191&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120124
About The Article: This narrative review from the International Antiviral Society–USA provides updated 2024 recommendations for HIV treatment and clinical management and HIV prevention. New approaches for treating and preventing HIV offer additional tools to help end the HIV epidemic, but achieving this goal depends on addressing disparities and inequities in access to care.
Corresponding Author: To contact the corresponding author, Rajesh T. Gandhi, MD email RGANDHI@mgh.harvard.edu.
(doi:10.1001/jama.2024.24543)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Characterizing Services Advertised on Crisis Pregnancy Center Websites
JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, DECEMBER 2, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2024.6440?guestAccessKey=b2fb6757-2329-4c92-ae66-a4d07a5ee0ca&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120224
About The Study: The findings of this study suggest the need for greater scrutiny of crisis pregnancy center practices, particularly their service provision, provider qualifications, and how these conform with regulations or best practices. A key concern is their promotion of abortion pill reversal, which lacks FDA approval or scientific support and may cause harm.
Corresponding Author: To contact the corresponding author, John W. Ayers, PhD, MA, email ayers.john.w@gmail.com.
(doi:10.1001/jamainternmed.2024.6440)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Implementation of Electronic Triggers to Identify Diagnostic Errors in Emergency Departments
JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, DECEMBER 2, 2024
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2024.6214?guestAccessKey=78114fab-14e2-47fa-88a4-82504b85ee7f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120224
About The Study: In this retrospective medical record review study, rules-based e-triggers were useful for post hoc detection of missed opportunities in diagnosis in emergency department visits. Interventions to target emergency department work system factors are urgently needed to support patient-clinician encounters and minimize harm from diagnostic errors.
Corresponding Author: To contact the corresponding author, Hardeep Singh, MD, MPH, email hardeeps@bcm.edu.
(doi:10.1001/jamainternmed.2024.6214)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Launch and Postlaunch Price Developments of New Drugs in the US, Germany, and Switzerland
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.4461?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112724
About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
Colorectal Cancer Incidence and Mortality After Negative Colonoscopy Screening Results
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.5227?guestAccessKey=8b2a0d69-fed7-4d20-8ef5-76e91cfb1dac&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112724
Social Vulnerability, Intervention Utilization, and Outcomes in US Adults Hospitalized With Influenza
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.48003?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112724
Ultraprocessed Food Intake and Psoriasis
JAMA Dermatology
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 27, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2024.4832?guestAccessKey=fc814931-608e-4685-8bb5-ed1011e77e18&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112724
About The Study: The results of this study showed an association between high ultraprocessed food intake and active psoriasis status. After adjustments for age, body mass index (BMI), alcohol intake, and comorbidities, the results remained significant, suggesting that ultraprocessed food intake has a proinflammatory action separate from high BMI.
Corresponding Author: To contact the corresponding author, Emilie Sbidian, MD, PhD, email emilie.sbidian@aphp.fr.
(doi:10.1001/jamadermatol.2024.4832)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Race and Ethnicity, Gender, and Promotion of Physicians in Academic Medicine
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, WEDNESDAY, NOVEMBER 27, 2024
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.46018?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112724
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: The findings of this study indicate that preferential promotion of white men within academic medicine continues to persist in the new millennium, with racially and ethnically diverse women experiencing greater underpromotion. To achieve a workforce that reflects the diversity of the U.S. population, this study suggests that academic medicine needs to transform its culture and practices surrounding faculty appointments and promotions.
Corresponding Author: To contact the corresponding author, Lauren Clark, MS, email lclark5@kumc.edu.
(doi:10.1001/jamanetworkopen.2024.46018)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Testing and Masking Policies and Hospital-Onset Respiratory Viral Infections
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, WEDNESDAY, NOVEMBER 27, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.48063?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112724
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: In this study, stopping universal masking and SARS-CoV-2 testing was associated with a significant increase in hospital-onset respiratory viral infections relative to community infections. Restarting the masking of health care workers was associated with a significant decrease.
Corresponding Author: To contact the corresponding author, Theodore R. Pak, MD, PhD, email tpak@mgh.harvard.edu.
(doi:10.1001/jamanetworkopen.2024.48063)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Geographic Disparities in Gynecologic Oncology Clinical Trial Availability in the US
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.47635?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112624
Virtual Home Care for Patients With Acute Illness
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.47352?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112624
Collaborative Care Model for Patients With Opioid Use Disorder and Mental Illness
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49012?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112624
Alcohol Use and Antiobesity Medication Treatment
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, TUESDAY, NOVEMBER 26, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.47644?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112624
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: This cohort study among individuals participating in a weight loss program found that nearly half of those consuming alcohol at baseline decreased their alcohol use after anti-obesity medication initiation. There may be properties of anti-obesity medications that lead to reduced use. For example, naltrexone decreases cravings for alcohol and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may attenuate the rewarding effects of alcohol, similar to food.
Corresponding Author: To contact the corresponding author, Lisa R. Miller-Matero, PhD, email lmatero1@hfhs.org.
(doi:10.1001/jamanetworkopen.2024.47644)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Cervical Cancer Mortality Among US Women Younger Than Age 25
JAMA
EMBARGOED FOR RELEASE: 11 A.M. ET, WEDNESDAY, NOVEMBER 27, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.22169?guestAccessKey=96c86a3c-4972-4bcc-8b6a-5957503cab01&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112724
About The Study: This study found a steep decline in cervical cancer mortality among U.S. women younger than 25 years between 2016 and 2021. This cohort of women is the first to be widely protected against cervical cancer by human papillomavirus (HPV) vaccines. The findings from this study in the context of other published research suggest that HPV vaccination affected the sequential decline in HPV infection prevalence, cervical cancer incidence, and cervical cancer mortality.
Corresponding Author: To contact the corresponding author, Ashish A. Deshmukh, PhD, MPH, email deshmukha@musc.edu.
(doi:10.1001/jama.2024.22169)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Association of Severe Maternal Morbidity With Subsequent Birth
JAMA
EMBARGOED FOR RELEASE: 11 A.M. ET, MONDAY, NOVEMBER 25, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20957?guestAccessKey=d104ece7-2c79-4a1c-ae18-3b23e049c6e6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112524
About The Study: The findings of this study suggest that women who experience severe maternal morbidity in their first birth are less likely to have a subsequent birth. Adequate reproductive counseling and enhancing antenatal care are crucial for women with a history of severe maternal morbidity.
Corresponding Author: To contact the corresponding author, Eleni Tsamantioti, MD, MMedSc, email eleni.tsamantioti@ki.se.
(doi:10.1001/jama.2024.20957)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Modeling Health and Economic Outcomes of Eliminating Sex Disparities in Youth Physical Activity
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.46775?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112524
Antihypertensive Deprescribing and Cardiovascular Events Among Long-Term Care Residents
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.46851?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112524
Psychological Resilience and Frailty Progression in Older Adults
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.47605?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112524
Wildfire Smoke Exposure and Incident Dementia
JAMA Neurology
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, NOVEMBER 25, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2024.4058?guestAccessKey=fa5fca5a-bcdf-4801-a2dc-81b6e87b95dd&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112524
About The Study: In this cohort study, after adjusting for measured confounders, long-term exposure to wildfire and non-wildfire fine particulate matter (PM2.5) over a 3-year period was associated with dementia diagnoses. As the climate changes, interventions focused on reducing wildfire PM2.5 exposure may reduce dementia diagnoses and related inequities.
Corresponding Author: To contact the corresponding author, Joan A. Casey, PhD, email jacasey@uw.edu.
(doi:10.1001/jamaneurol.2024.4058)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
COVID-19 Vaccine Reactogenicity Among Young Children
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, MONDAY, NOVEMBER 25, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.47492?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112524
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: No unexpected reactions were identified in this analysis of reactions to COVID-19 vaccines among children. Similar to this study, data from clinical trials and V-safe found that irritability was the most common systemic reaction among children ages 6 months to younger than 2 years, followed by fever and fatigue or sleepiness. In contrast to other studies observing a higher prevalence of reactions after the second COVID-19 vaccine dose, this study observed a higher prevalence after the first dose. This difference may reflect maternal vaccination; the first COVID-19 vaccination in this cohort may be some children’s second immunological encounter with a COVID-19 vaccine.
Corresponding Author: To contact the corresponding author, Andrea J. Sharma, PhD, MPH, email aec4@cdc.gov.
(doi:10.1001/jamanetworkopen.2024.47492)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Generalizability of Clinical Trials of Novel Weight Loss Medications to the US Adult Population
JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, NOVEMBER 25, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2024.6340?guestAccessKey=f706964e-006e-4c93-9e47-75456cc57d5f&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112524
About The Study: This study estimates that approximately one-third of U.S. adults without diabetes who were eligible for weight loss treatment with glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GLP-1/GIP) were excluded from clinical trials supporting these medications’ safety and effectiveness. Until there is evidence from high-quality postmarketing studies, the FDA should consider updating labeling to advise caution on generalizing the safety and effectiveness of GLP-1 and GLP-1/GIP to populations excluded from pivotal trials.
Corresponding Author: To contact the corresponding author, Timothy S. Anderson, MD, MAS, email tsander@pitt.edu.
(doi:10.1001/jamainternmed.2024.6340)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
AI and Radiologist Burnout
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.48714?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112224
US Pediatric Inpatient Care Loss Before and During the COVID-19 Pandemic
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.46025?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112224
Health Care Utilization With Telemedicine and In-Person Visits in Pediatric Primary Care
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.4156?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112224
About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
Hearing Aid Use at the Intersection of Race, Ethnicity, and Socioeconomic Status
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.3854?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112224
About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
Disparities by Race and Urbanicity in Online Health Care Facility Reviews
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, FRIDAY, NOVEMBER 22, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.46890?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112224
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: This serial cross-sectional study observed a significant decrease in positive reviews for health care facilities post-COVID. These findings underscore a disparity in patient experience, particularly in rural areas and areas with the highest proportions of Black and white residents.
Corresponding Author: To contact the corresponding author, Neil K. R. Sehgal, ME, email neilsehgal99@gmail.com.
(doi:10.1001/jamanetworkopen.2024.46890)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Racial and Ethnic Variation in Survival in Early-Onset Colorectal Cancer
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, FRIDAY, NOVEMBER 22, 2024
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.46820?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112224
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: In this cohort study, racial and ethnic disparities in early-onset (before 50 years of age) colorectal cancer mortality were evident, with the highest burden among Native Hawaiian or Other Pacific Islander and non-Hispanic Black individuals. These results provide evidence of the role of social determinants of health in explaining these differences.
Corresponding Author: To contact the corresponding author, Maria Elena Martinez, PhD, email e8martinez@health.ucsd.edu.
(doi:10.1001/jamanetworkopen.2024.46820)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Characteristics of Academic Inventors on Government-Linked US Drug Patents
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20361?guestAccessKey=6f501a58-e21a-464e-8d7e-44da6279ecba&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112124
A Hearing Intervention and Health-Related Quality of Life in Older Adults
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.46591?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112124
National and Regional Trends in Police Pursuit Fatalities in the US
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.46415?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112124
Physical Activity and All-Cause Mortality by Age in 4 Multinational Megacohorts
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, THURSDAY, NOVEMBER 21, 2024
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.46802?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112124
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: In this pooled analysis of cohort studies, the association between physical activity and mortality risk remained consistent across the adult lifespan, which contrasts with other modifiable health factors, for which associations with mortality risk diminished with age. Given these findings, the promotion of regular physical activity is essential at all stages of adult life.
Corresponding Author: To contact the corresponding author, David Martinez-Gomez, PhD, email d.martinez@uam.es.
(doi:10.1001/jamanetworkopen.2024.46802)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Prenatal Diet and Infant Growth From Birth to Age 24 Months
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, THURSDAY, NOVEMBER 21, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.45771?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112124
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: In this cohort study, a prenatal diet that aligned with the U.S. Dietary Guidelines was associated with reduced patterns of rapid and slow infant growth, known risk factors associated with obesity. Future research should examine whether interventions to improve prenatal diet are also beneficial in improving growth trajectory in children.
Corresponding Author: To contact the corresponding author, Monique M. Hedderson, PhD, email Monique.m.Hedderson@kp.org.
(doi:10.1001/jamanetworkopen.2024.45771)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Obesity Prevention at an Early Age
JAMA
EMBARGOED FOR RELEASE: 11 A.M. ET, THURSDAY, NOVEMBER 21, 2024
Media advisory: The full editorial and related study are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.24026?guestAccessKey=c7eccafa-607a-4498-8c3a-4ccd99bf8ca4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112124
About The Article: This editorial places results of the Greenlight Plus trial, recently published by JAMA, in context, including technological interventions and policies to help prevent childhood obesity.
Corresponding Author: To contact the corresponding author, Kevin G. Volpp, MD, PhD, email volpp70@wharton.upenn.edu.
(doi:10.1001/jama.2024.24026)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Alternative LDL Cholesterol–Lowering Strategy vs High-Intensity Statins in Atherosclerotic Cardiovascular Disease
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2024.3911?guestAccessKey=cec81e25-2fa8-4f0f-b44a-1c74e626aa70&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112024
War Exposure and DNA Methylation in Syrian Refugee Children and Adolescents
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2024.3714?guestAccessKey=f345dbe4-3435-4642-a139-1eedc8c88225&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112024
Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2024.4593?guestAccessKey=83342a01-1d18-4329-8d02-08043480df25&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112024
Bioengineered Human Arteries for the Repair of Vascular Injuries
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2024.4893?guestAccessKey=b26eb658-9b4e-4dfe-a852-eefe068f1960&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112024
Outdoor Artificial Light at Night and Insomnia-Related Social Media Posts
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.46156?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112024
Short-Term and Long-Term Mortality Risk After Preterm Birth
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, WEDNESDAY, NOVEMBER 20, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.45871?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112024
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: The findings of this population-based matched cohort study suggest that individuals born preterm were at an increased risk of death from birth until their third and fourth decades of life, with higher risks as gestational age decreased. Some of these associations may have been partly due to underlying health determinants that affected preterm birth and mortality. These findings suggest that preterm birth should be recognized as a risk factor for mortality and could inform preventive strategies.
Corresponding Author: To contact the corresponding author, Asma M. Ahmed, PhD, MD, MPH, email asahmed@wakehealth.edu.
(doi:10.1001/jamanetworkopen.2024.45871)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Trends in Postpartum Depression by Race, Ethnicity, and Prepregnancy BMI
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. ET, WEDNESDAY, NOVEMBER 20, 2024
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.46486?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112024
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: In this cross-sectional study, postpartum depression (PPD) diagnosis increased significantly across all racial and ethnic groups and body mass index (BMI) categories over the past decade. While rising PPD may reflect improved screening and diagnosis practices, the persistently high rates highlight the need to develop and implement interventions to prevent the condition while expanding efforts to mitigate the impact of PPD on maternal and child health.
Corresponding Author: To contact the corresponding author, Darios Getahun, MD, PhD, MPH, email darios.t.getahun@kp.org.
(doi:10.1001/jamanetworkopen.2024.46486)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Partial Cardiac Denervation to Prevent Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting
JAMA Cardiology
EMBARGOED FOR RELEASE: 9:15 A.M. (ET), SUNDAY, NOVEMBER 17, 2024
Media advisory: The full study is linked to this news release. This study is being presented at the American Heart Association’s Scientific Sessions 2024.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2024.4639?guestAccessKey=508520f8-6b48-4a01-9cc3-7903d9033804&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111724
About The Study: This randomized clinical trial found that partial cardiac denervation was an effective procedure to reduce the occurrence of postoperative atrial fibrillation (POAF) after isolated coronary artery bypass grafting (CABG) without additional postoperative complications. These results suggest that partial cardiac denervation may be a good option for cardiac surgeons to consider for preventing POAF after CABG.
Corresponding Authors: To contact the corresponding authors, email Wei Feng, MD, PhD (fengwei@fuwai.com) and Wei Zhao, MD, PhD (zhaowei_fw@163.com).
(doi:10.1001/jamacardio.2024.4639)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction
JAMA Cardiology
EMBARGOED FOR RELEASE: 9:20 A.M. (ET), SUNDAY, NOVEMBER 17, 2024
Media advisory: The full study and editor’s note are linked to this news release. This study is being presented at the American Heart Association’s Scientific Sessions 2024.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2024.4613?guestAccessKey=5fb154f0-48a7-4e77-b600-7bbc93c0d382&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111724
About The Study: In the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients with Heart Failure (FINEARTS-HF), finerenone reduced the risk of the primary end point similarly in women and men with heart failure with mildly reduced or preserved ejection fraction. Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, had similar tolerability in women and men.
Corresponding Author: To contact the corresponding author, John J. V. McMurray, MD, email john.mcmurray@glasgow.ac.uk.
(doi:10.1001/jamacardio.2024.4613)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
JAMA Cardiology
EMBARGOED FOR RELEASE: 9:30 A.M. (ET), SUNDAY, NOVEMBER 17, 2024
Media advisory: The full study and commentary are linked to this news release. This study is being presented at the American Heart Association’s Scientific Sessions 2024.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2024.4539?guestAccessKey=678be14b-d387-47e1-a4e9-b4d11d8b5657&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111724
About The Study: In patients with heart failure with mildly reduced or preserved ejection fraction, finerenone, a nonsteroidal mineralocorticoid receptor antagonist, resulted in more frequent hyperkalemia and less frequent hypokalemia. However, with protocol-directed surveillance and dose adjustment, clinical benefit associated with finerenone relative to placebo was maintained even in those whose potassium level increased to greater than 5.5 mmol/L.
Corresponding Author: To contact the corresponding author, Scott D. Solomon, MD, email ssolomon@rics.bwh.harvard.edu.
(doi:10.1001/jamacardio.2024.4539)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.